Prenetics Global Ltd. has reaffirmed its full-year 2025 revenue guidance, projecting total revenues of $90 to $100 million. The company expects its IM8 business unit to contribute $60 million in revenue for the year. For the fourth quarter of 2025, Prenetics has provided revenue guidance of $28 million for IM8, representing a 63% increase quarter-over-quarter compared to the third quarter of 2025. Looking ahead to 2026, IM8's full-year revenue is expected to reach between $180 and $200 million, with a target of approximately $25 million in monthly revenue or $300 million in annual recurring revenue $(ARR)$ by the end of 2026. This outlook follows a significant surge in business performance, as Prenetics reported a 567.7% year-over-year increase in total revenue to $23.6 million for the third quarter of 2025, and a 631.2% rise in gross profit to $14.0 million over the same period.